Anxiety Disorders

Häftad, Engelska, 2015

AvKerry J. Ressler,Daniel S. Pine,Barbara Olasov Rothbaum,GA) Ressler, Kerry J. (MD, PhD, Professor, MD, PhD, Professor, Center for Behavioral Neuroscience, Department of Psychiatry and Behavioral Sciences, Yerkes Research Ctr, Emory University, Atlanta,MD) Pine, Daniel S. (MD, Chief, MD, Chief, Section on Development and Affective Neuroscience, Mood and Anxiety Disorders Program, Intramural Research Program, National Institute of Mental Health, Bethesda,GA) Rothbaum, Barbara Olasov (PhD, Professor, PhD, Professor, Emory University School of Medicine, Department of Psychiatry and Behavioral Sciences, Atlanta,Kerry Ressler,Daniel Pine,Barbara Rothbaum

1 809 kr

Beställningsvara. Skickas inom 5-8 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

Anxiety affects millions, manifesting as generalized anxiety disorder (GAD), obsessive compulsive disorder, panic disorder, phobias, post-traumatic-stress disorder (PTSD), and social anxiety disorder. Not only are anxiety disorders common, but they are also crippling, frequently co-occurring and predict high risk for depressive disorders. Shared mechanisms may explain the overlapping features of many anxiety disorders and account for associations with other highly-impairing conditions, such as major depression and substance use. Beyond risk for specific disorders, anxiety also predicts a number of other adverse outcomes, including suicidal behavior, medical problems, social, and economic difficulties. Conversely, disorder-specific mechanisms may also exist and explain the unique features of each syndrome. Thus, it is important to understand both shared and specific aspects of anxiety. The Primer on Anxiety Disorders provides early-stage practitioners and trainees, as well as seasoned clinicians and researchers, with need-to-know knowledge on diagnosis and treatment. Clinical cases are used throughout the book to enhance understanding of and illustrate specific disorders, comorbid conditions and clinical issues. To facilitate an integrative approach, content allows clinicians to understand patient characteristics and tailor interventions. The integrated approach of each chapter includes recent research on genetics and neuroscience to understand the mechanisms of anxiety disorders, focusing on the forthcoming new nosology in DSM-5. Chapters further integrate innovative advances in clinical research providing research on a range of discoveries regarding biomarkers of illness, biological predictors of treatments and the effect of treatment on neurocircuitry.

Produktinformation

Utgivningsdatum2015-05-21
Mått175 x 249 x 27 mm
Vikt930 g
FormatHäftad
SpråkEngelska
SeriePrimer On
Antal sidor528
FörlagOUP USA
ISBN9780199395125

Tillhör följande kategorier

Psykiatri inom Medicin
Klinisk psykologi inom Medicin
Biologisk psykologi och neuropsykologi inom Psykologi och pedagogik

Kerry J. Ressler, Professor of Psychiatry and Behavioral Sciences at Emory University, received his B.S. degree in molecular biology from M.I.T., and his M.D./Ph.D. from Harvard Medical School. His work focuses on translational research bridging molecular neurobiology in animal models with human genetic research. His basic and clinical research examines neurobiological, molecular, genetic and behavioral processes that underlie fear related processing and Posttraumatic Stress Disorder.Dr. Daniel S. Pine is Chief, Section on Development and Affective Neuroscience, in the National Institute of Mental Health Intramural Research Program. Since graduating from medical school at the University of Chicago, Dr. Pine has been engaged continuously in research on pediatric mental disorders. Currently, his group examines the degree to which mood and anxiety disorders in children and adolescents are associated with abnormalities in the amygdala, prefrontal cortex, and brain regions that modulate these structures.Barbara Olasov Rothbaum, Ph.D. is a professor in psychiatry and Associate Vice Chair of Clinical Research at the Emory School of Medicine in the Department of Psychiatry and Behavioral Sciences and director of the Trauma and Anxiety Recovery Program at Emory. Dr. Rothbaum specializes in research on the treatment of individuals with anxiety disorders, particularly focusing on Posttraumatic Stress Disorder (PTSD).

Foreword: Anxiety Disorders, Big Science, and Big Data: The Next Generation of Science and Practice ; Section 1: Overview of Anxiety and Related Illnesses ; 1. Anxiety and Related Disorders in DSM5. ; 2. Translational Perspectives, RDoC and Anxiety. ; Section 2: Neurobiology and Neural Circuitry of Anxiety Disorders ; 3. Neurobiology and Neuroimaging of Fear and Anxiety Circuitry. ; 4. The Genetics of Anxiety Disorders. ; Section 3: Development of Fear, Fear Pathways, and Anxiety Disorders in Children and Adolescents ; 5. Developmental Biology related to Emotion and Anxiety. ; 6. Development of Fear and its Inhibition ; 7. Involving the Family in Treatment. ; 8. Treating the College-age Patient. ; Section 4: Posttraumatic Stress and the Neurobiology of Trauma ; 9. PTSD and the Biology of the Stress Response. ; 10. Clinical Aspects of Trauma-related Anxiety and PTSD. ; Section 6: Obsessive Compulsive and Disorders of Cortical-Striatal Processing ; 11. Dissecting OCD Circuits: From Animal Models to Targeted Treatments. ; 12. Clinical aspects of Obsessive Compulsive Disorder. ; Section 7: Phobias, Fears, and Panic ; 13. The Etiology of Fear and Anxiety: The Role of Environmental Exposures. ; 14. Clinical Aspects of Social Anxiety Disorder and Specific Phobias. ; 15. Clinical aspects of Panic disorder. ; Section 8: Intersection of Medical and Anxiety Disorders ; 16. Fear, Anxiety, Avoidance, and Chronic Pain. ; 17. Detection and Treatment of Anxiety Disorders in Primary Care Settings. ; 18. Gastrointestinal Disorders, Irritable Bowel Syndrome, and Anxiety. ; 19. Anxiety Disorders and Cardiovascular Illness. ; Section 9: Intersection of Anxiety with Mood and Substance Disorders ; 20. Substance abuse and Comorbidity with Anxiety. ; 21. Comorbidity of Anxiety and Depression. ; 22. Generalized Anxiety Disorder. ; 23. Anxiety and Suicide. ; Section 10: Cognitive and Exposure Based Treatments of Anxiety Disorders ; 24. Neural Circuitry Mechanisms of Fear Extinction. ; 25. Learning Theory and Cognitive Behavioral Therapy. ; 26. Pharmacological Mechanisms of Modulating Fear and Extinction. ; Section 11: Neurotransmitter Pathways and Pharmacological Treatments of Anxiety Disorders ; 27. Stress, Anxiety, Depression and the Role of Glutamate Neurotransmission. ; 28. The Role of the Hypothalamic-Pituitary-Adrenal Axis in Anxiety Disorders. ; 29. Pharmacological Interventions for Adult Anxiety Disorders. ; Section 12: New Technologies and Approaches to Treatment ; 30. Adherence to Psychotherapy and Pharmacotherapy for Anxiety Disorders. ; 31. Computer Tools as Novel Treatment for Depression and Anxiety. ; 32. Internet-Based Treatment for Anxiety, OCD, and Related Disorders.

All clinicians and clinical scientists working in anxiety disorders who would like a vision of where the field will be in 5 to 10 years should read this Primer. With three of the leading clinical investigators in the world as Editors, and with a first-rate roster of contributors covering all the latest findings from neurotransmitter underpinnings of drug treatments to the neuroscience of psychological treatments, readers can preview likely changes in diagnosis, assessment, and treatment in the years to come. Most importantly, we get a glimpse of a future in which we can individualize treatment based on a sound set of scientifically validated predictors of outcome. A must read!" - David H. Barlow PhD, ABPP, Professor of Psychology and Psychiatry, Boston University, Founder and Director Emeritus, Center for Anxiety and Related Disorders, Boston, MA